3251 - 3275 of 9038 Results
Title
Year
-
OPENTitle: Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross‐Sectional Survey of 568 Spanish PatientsJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 10Start Page: 1712End Page: 1716Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28261Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28261Citation Count: 64
-
OPENTitle: A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System AtrophyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1957End Page: 1965Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28218Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28218Citation Count: 81
-
OPENTitle: Movement Disorder Society–Unified Parkinson's Disease Rating Scale Use in the Covid‐19 EraJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 911End Page: 911Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28094Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28094Citation Count: 39
- Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo‐Controlled Trial2020RESTRICTEDTitle: Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo‐Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2250End Page: 2260Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28248Citation Count: 69
- Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's Disease2020OPENTitle: Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1416End Page: 1427Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28064Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28064Citation Count: 80
- Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's Disease2020RESTRICTEDTitle: Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1245End Page: 1248Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28037Citation Count: 57
- Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations2020OPENTitle: Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and RecommendationsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 283End Page: 297Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1002/mds.28313Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28313Citation Count: 87
-
OPENTitle: A New Day: The Role of Telemedicine in Reshaping Care for Persons With Movement DisordersJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1897End Page: 1902Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28296Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28296Citation Count: 55
-
OPENTitle: Four‐Year Follow‐up of [18F]Fluorodeoxyglucose Positron Emission Tomography–Based Parkinson's Disease–Related Pattern Expression in 20 Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 230End Page: 235Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28260Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28260Citation Count: 47
-
OPENTitle: GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian CohortJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2106End Page: 2111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28195Best OA location URL: http://hdl.handle.net/11573/1433077Citation Count: 144
-
OPENTitle: A Large‐Scale Full GBA1 Gene Screening in Parkinson's Disease in the NetherlandsJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 9Start Page: 1667End Page: 1674Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28112Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28112Citation Count: 71
- PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression2020RESTRICTEDTitle: PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 606End Page: 615Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27963Citation Count: 40
-
OPENTitle: Modernizing Daily Function Assessment in Parkinson's Disease Using Capacity, Perception, and Performance MeasuresJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 76End Page: 82Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28377Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28377Citation Count: 66
- Telemedicine in Movement Disorders: Leçons du COVID‐192020RESTRICTEDTitle: Telemedicine in Movement Disorders: Leçons du COVID‐19Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1893End Page: 1896Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28297Citation Count: 30
-
OPENTitle: Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrainJournal Name: Brain, Behavior, and ImmunityPublisher: Elsevier BVVol: 111Issue #:Start Page: 277End Page: 291Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbi.2023.04.008Best OA location URL: https://doi.org/10.1016/j.bbi.2023.04.008Citation Count: 20
-
OPENTitle: Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau PathologyJournal Name: Clinical ChemistryPublisher: Oxford University Press (OUP)Vol: 69Issue #: 11Start Page: 1247End Page: 1259Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/clinchem/hvad139Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10895336/pdf/nihms-1962140.pdfCitation Count: 39
-
OPENTitle: The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 7Start Page: 3158End Page: 3170Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12966Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12966Citation Count: 26
-
OPENTitle: Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classificationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 190Issue #:Start Page: 106373End Page: 106373Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106373Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106373Citation Count: 43
-
OPENTitle: The misallocation of climate research fundingJournal Name: Energy Research & Social SciencePublisher: Elsevier BVVol: 62Issue #:Start Page: 101349End Page: 101349Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.erss.2019.101349Best OA location URL: https://doi.org/10.1016/j.erss.2019.101349Citation Count: 287
-
OPENTitle: Mechanisms controlling selective elimination of damaged lysosomesJournal Name: Current Opinion in PhysiologyPublisher: Elsevier BVVol: 29Issue #:Start Page: 100590End Page: 100590Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cophys.2022.100590Best OA location URL: https://doi.org/10.1016/j.cophys.2022.100590Citation Count: 33
-
OPENTitle: Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1781End Page: 1782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29131Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9756875Citation Count: 1
-
OPENTitle: The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1778Issue #:Start Page: 147781End Page: 147781Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2022.147781Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S0006899322000051-ga1_lrg.jpgCitation Count: 23
-
OPENTitle: Vesicular dysfunction and pathways to neurodegenerationJournal Name: Essays in BiochemistryPublisher: Portland Press Ltd.Vol: 65Issue #: 7Start Page: 941End Page: 948Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/ebc20210034Best OA location URL: https://portlandpress.com/essaysbiochem/article-pdf/65/7/941/929366/ebc-2021-0034c.pdfCitation Count: 13
- A step forward for LRRK2 inhibitors in Parkinson’s disease2022OPENTitle: A step forward for LRRK2 inhibitors in Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 648Start Page: eabq7374End Page: eabq7374Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abq7374Citation Count: 20
-
OPENTitle: From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's diseaseJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 14Start Page: 2945End Page: 2951Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20210383Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/14/2945/918073/bcj-2021-0383.pdfCitation Count: 5
